Document Detail

Public health impact of antiviral therapy for hepatitis C in the United States.
MedLine Citation:
PMID:  19824079     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Efforts to improve rates of diagnosis and treatment will be required if the future public health burden of hepatitis C is to be ameliorated.
Michael L Volk; Rachel Tocco; Sameer Saini; Anna S F Lok
Related Documents :
19925399 - Diabetes trends in hospitalized hiv-infected persons in the united states, 1994-2004.
16389249 - Changes in invasive pneumococcal disease among hiv-infected adults living in the era of...
16464269 - Evaluation of time for non-gu medicine physicians to diagnose hiv infection in patients...
8902069 - Toxoplasmic encephalitis in hiv-infected persons: risk factors and trends. the adult/ad...
10668839 - Marked declines in human immunodeficiency virus-related mortality in chicago in women, ...
8246859 - Hiv transmission between two adolescent brothers with hemophilia.
18414109 - No association between helicobacter pylori infection or caga-bearing strains and glaucoma.
9071279 - Hiv and hepatitis b infection and risk behavior in young gay and bisexual men.
15097299 - Changes in total lymphocyte count as a surrogate for changes in cd4 count following ini...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  50     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-27     Completed Date:  2009-12-15     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1750-5     Citation Subset:  IM    
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 48109, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / therapeutic use*
Cost of Illness
Hepatitis C / drug therapy*,  virology
Markov Chains
Public Health*
United States
Reg. No./Substance:
0/Antiviral Agents
Erratum In:
Hepatology. 2010 Feb;51(2):725

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.
Next Document:  Generation of Thymic Epithelial Cell Progenitors by Mouse Embryonic Stem Cells.